GHC vs. WST
Compare and contrast key facts about Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GHC or WST.
Correlation
The correlation between GHC and WST is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GHC vs. WST - Performance Comparison
Loading data...
Key characteristics
GHC:
0.92
WST:
-0.76
GHC:
1.64
WST:
-0.79
GHC:
1.19
WST:
0.85
GHC:
2.09
WST:
-0.71
GHC:
5.05
WST:
-1.80
GHC:
6.01%
WST:
23.27%
GHC:
30.77%
WST:
54.56%
GHC:
-67.54%
WST:
-59.29%
GHC:
-3.10%
WST:
-54.40%
Fundamentals
GHC:
$4.23B
WST:
$15.43B
GHC:
$141.16
WST:
$6.37
GHC:
6.88
WST:
33.45
GHC:
0.00
WST:
3.61
GHC:
0.88
WST:
5.33
GHC:
0.99
WST:
5.75
GHC:
$4.80B
WST:
$2.90B
GHC:
$1.42B
WST:
$1.00B
GHC:
$1.24B
WST:
$729.50M
Returns By Period
In the year-to-date period, GHC achieves a 11.75% return, which is significantly higher than WST's -34.85% return. Over the past 10 years, GHC has underperformed WST with an annualized return of 6.07%, while WST has yielded a comparatively higher 15.26% annualized return.
GHC
11.75%
7.17%
1.46%
27.56%
24.51%
6.07%
WST
-34.85%
4.67%
-34.11%
-41.33%
0.51%
15.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GHC vs. WST — Risk-Adjusted Performance Rank
GHC
WST
GHC vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GHC vs. WST - Dividend Comparison
GHC's dividend yield for the trailing twelve months is around 0.73%, more than WST's 0.39% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GHC Graham Holdings Company | 0.73% | 0.79% | 0.95% | 1.05% | 0.96% | 1.09% | 0.87% | 0.83% | 0.91% | 0.95% | 1.77% | 1.18% |
WST West Pharmaceutical Services, Inc. | 0.39% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
GHC vs. WST - Drawdown Comparison
The maximum GHC drawdown since its inception was -67.54%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for GHC and WST. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GHC vs. WST - Volatility Comparison
The current volatility for Graham Holdings Company (GHC) is 7.30%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 9.88%. This indicates that GHC experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GHC vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Graham Holdings Company and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GHC vs. WST - Profitability Comparison
GHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a gross profit of 346.56M and revenue of 1.17B. Therefore, the gross margin over that period was 29.7%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
GHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported an operating income of 47.47M and revenue of 1.17B, resulting in an operating margin of 4.1%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
GHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a net income of 23.89M and revenue of 1.17B, resulting in a net margin of 2.1%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.